Development of multiplex real-time PCR for detection of clarithromycin resistance genes for the Mycobacterium abscessus group
Journal of Medical Microbiology · 16.03.2023 · 72 (3)
DOI: 10.1099/jmm.0.001670 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medical Microbiology, erschienen am 16.03.2023. Verfasst von Carolina Salgado Pedace und 6 weiteren Autor:innen. Beteiligte Einrichtung: Tuberculosis and Mycobacteriosis Branch, Bacteriology Center, Adolfo Lutz Institute, Avenida Doutor Arnaldo, 351 - 9th floor - Pacaembu, 01246000, Sã…. Hauptthemen laut MEDLINE: Mycobacterium abscessus, Mycobacterium Infections, Nontuberculous. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: Fundação de Amparo à Pesquisa do Estado de São Paulo.
Abstract (Originalsprache)
Introduction
The M. abscessus molecular identification and its drug-resistance profile are important to choose the correct therapy.
Aim
This work developed a multiplex real-time PCR (mqPCR) for detection of clarithromycin resistance genes for the Mycobacterium abscessus group. Methodology. Isolates received by Adolfo Lutz Institute from 2010 to 2012, identified by PCR restriction enzyme analysis of a fragment of the hsp 65 gene (PRA- hsp 65) as M. abscessus type 1 ( n =135) and 2 ( n =71) were used. Drug susceptibility test (DST) for CLA were performed with reading on days 3 and 14. Subespecies identification by hsp 65 and rpo B genes sequencing and erm (41) and rrl genes for mutation detection and primer design were performed. erm (41) gene deletion was detected by conventional PCR. Primers and probes were designed for five detections: erm (41) gene full size and with deletion; erm (41) gene T28 and C28; rrl gene A2058.
Results
In total, 191/206 (92.7 %) isolates were concordant by all methods and 13/206 (6.3 %) were concordant only between molecular methods. Two isolates (1.0 %) were discordant by mqPCR compared to rrl gene sequencing. The mqPCR obtained 204/206 (99.0 %) isolates in agreement with the gold standard, with sensitivity and specificity of 98 and 100 %, respectively, considering the gold standard method and 92 and 93 % regarding DST.
Conclusion
The mqPCR developed by us proved to be an easy-to-apply tool, minimizing time, errors and contamination.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Tuberculosis and Mycobacteriosis Branch, Bacteriology Center, Adolfo Lutz Institute, Avenida Doutor Arnaldo, 351 - 9th floor - Pacaembu, 01246000, São Paulo, Brazil.
- Immunology Center, Adolfo Lutz Institute, Avenida Doutor Arnaldo, 351 - 10th floor - Pacaembu, 01246000, São Paulo, Brazil.
Förderung
- Fundação de Amparo à Pesquisa do Estado de São Paulo
Zitieren
APA
Pedace, C. S., Gonçalves, M. G., Souza, A. R., Dos Santos Simeão, F. C., de Carvalho, N. F. G., Gallo, J. F., & Chimara, E. (2023). Development of multiplex real-time PCR for detection of clarithromycin resistance genes for the Mycobacterium abscessus group. Journal of Medical Microbiology, 72(3). https://doi.org/10.1099/jmm.0.001670
Vancouver
Pedace CS, Gonçalves MG, Souza AR, Dos Santos Simeão FC, de Carvalho NFG, Gallo JF, et al. Development of multiplex real-time PCR for detection of clarithromycin resistance genes for the Mycobacterium abscessus group. Journal of Medical Microbiology. 2023;72(3). doi:10.1099/jmm.0.001670
BibTeX
@article{Pedace2023,
author = {Pedace, Carolina Salgado and Gonçalves, Maria Gisele and Souza, Andréia Rodrigues and Dos Santos Simeão, Fernanda Cristina and de Carvalho, Natalia Fernandes Garcia and Gallo, Juliana Failde and Chimara, Erica},
title = {Development of multiplex real-time PCR for detection of clarithromycin resistance genes for the Mycobacterium abscessus group},
journal = {Journal of Medical Microbiology},
year = {2023},
volume = {72},
number = {3},
doi = {10.1099/jmm.0.001670}
}
EUVIMED